Mutual Fund

Fund Card

DSP Healthcare Fund-Reg(G)

very highequitypharma & health care

38.11 -0.12(-0.30%) NAV as on 27 Feb 2026

2.22 % 1 M

3.96 % 1 Y

22.02 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

FUND OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

SCHEME DETAILS

Expenses Ratio :

1.94

As on 31 Jan, 2026

Age :

7 yrs 3 m

Since 30 11 ,2018

Exit Load :

0.5%

AUM :

2,971.07 Crs

Lock-in :

0.50% on or before 1M, Nil after 1M

Investing Style :

Small Growth

Portfolio Price To Book Value :

5.75

Min. Investment :

SIP 100 & Lumpsum 100

Scheme Benchmark :

Fund Manager :

Chirag Dagli

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jan 31 ,2026

Others 2.07 %

Equity 97.93 %

TOP HOLDINGS

Ipca Laboratories Ltd.8.40 %

Sun Pharmaceutical Industries...8.25 %

Cipla Ltd.8.08 %

Globus Medical Inc7.54 %

Illumina Inc.7.18 %

See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs	64.62
Hospital & Healthcare Services	12.15
Insurance	1.47
Retailing	0.52
Medical Equipment/Supplies/Accessories	0.18

See All Sectors

5-YEARS HISTORY

Financial Year	2021-2022	2022-2023	2023-2024	2024-2025	2025-2026
NAV in Rs (as on 27-Feb-2026)	21.88	20.91	32.76	37.40	38.11
Net Assets(Rs Crores) (as on 27-Feb-2026)	1291.46	1202.10	2352.32	3018.76	2971.07
Scheme Returns(%)(Absolute)	13.12	-4.60	56.86	13.41	3.85
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	44/75	61/76	20/90	17/102	81/117

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

DSP Healthcare Fund-Reg(G)Very HighEquity38.11-0.12(-0.30%)NAV As on 27 Feb, 2026

30-Nov-2018Inception Date

2,971.07AUM In Cr.

3.96%1Y

22.02%3Y

15.11%5Y

20.27%Since Inception